Penn Medicine, CHOP receive $25M anonymous gift to accelerate research in rare genetic brain disorders
The donation will establish the Center for Epilepsy and Neurodevelopmental Disorders, which will initially focus on developing therapies for disorders related to genetic mutations that are linked to a
Eidos LGBTQ+ Health Initiative Support Advances in LGBTQIA+ Health Startups
The goal of the partnership is to support founders and entrepreneurs with in-depth LGBTQ+ health knowledge and research expertise.
fake troo
Koo and Steager's magnetic, scalable, tether-free robotic devices can be used for diagnostics via retrieval and sampling of biofilms associated with infectious diseases.
Penn Scientists New Research Shows That a CAR-T gel Treatment May Be Able to Kill Residual Cancer Cells Left Over from Surgery
In the study, Penn scientists added CAR-T cells to a gel designed to prevent bleeding after surgery and applied it to the surgical wounds of mice after they had hard-to-treat tumors resected.
PCI Highlights mRNA Innovation at JPM
On January 9th, 2023 PCI was proud to present a star-studded program entitled “The Future of mRNA Technology” at Wharton San Francisco during the JP Morgan Healthcare Conference.
Microrobotics for Precision Biofilm Diagnostics and Treatment
Koo and Steager's magnetic, scalable, tether-free robotic devices can be used for diagnostics via retrieval and sampling of biofilms associated with infectious diseases as well as the assessment of bi
Katalin Karikó and Drew Weissman named to the National Inventors Hall of Fame
Karikó and Weissman were named to the National Inventors Hall of Fame for their mRNA research which made covid-19 vaccines possible.
Exyn Technologies Secures $35M in Series B Funding
Penn spinout Exyn Technologies, a pioneer in multi-platform robotic autonomy for complex, GPS-denied environments, had a $35 million Series B round at the end of 2022.
Penn’s Abramson Cancer Center Presents New Cancer Research at 2022 American Society of Hematology (ASH) Annual Meeting
Researchers from Penn’s Abramson Cancer Center presented the preliminary results of an ongoing Phase I clinical trial for a novel CAR T therapy to be used after cancer.
Penn Researchers Work On Reducing CO2 Emissions by Repurposing Waste from Industrial Mines
Peter Psarras, a research assistant professor in chemical and biomolecular engineering, and his colleagues are repurposing waste from industrial mines.